AVP and Stroke: Our findings support the beneficial use of plasma copeptin measurement in prognostication following stroke, thus indicating that a biomarker-based approach with the evaluation of copeptin may provide important insight into the recovery potential of each stroke survivor and significantly facilitate individualized stroke care.